Skip to main content

Find Clinical Trials

Home
Conditions
Pleural Effusion

Clinical trial condition

Pleural Effusion

Explore clinical trials studying Pleural Effusion. Study availability and eligibility vary by location and protocol.

87 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Pleural Effusion trial results

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

NCT03869697

Conditions: Malignant Pleural Effusions, Neoplasms, Neoplasms by Site, +7 more
Locations: Liverpool Hospital Liverpool, New South Wales, Australia

Orange Health Service Orange, New South Wales, Australia

The Royal Melbourne Hospital Parkville, Victoria, Australia

SCGH (Sir Charles Gairdner Hospital) Nedlands, Western Australia, Australia

View Trial Details

Completed

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT01302808

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +23 more
Locations: Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States

View Trial Details

Completed

The Value of PET-CT in Pleural Effusions

NCT03272997

Conditions: Hypersensitivity, Immune System Diseases, Neoplasms, +8 more
Locations: Naestved Hospital Næstved, Denmark

View Trial Details

Completed

The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion

NCT03270215

Conditions: Hypersensitivity, Immune System Diseases, Neoplasms, +8 more
Locations: Naestved Hospital Næstved, Denmark

View Trial Details

Completed

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

NCT00066404

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +114 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

NCT02674243

Conditions: Malignant Pleural Effusion, Neoplasms, Neoplasms by Site, +7 more
Locations: Department of surgery, Faculty of medicine, Chiang Mai University Hospital Chiang Mai, Chaing Mai, Thailand

View Trial Details

Completed

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

NCT00126581

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +20 more
Locations: East Bay Radiation Oncology Center Castro Valley, California, United States

Eden Hospital Medical Center Castro Valley, California, United States

Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States

Bay Area Breast Surgeons Inc Emeryville, California, United States

View all 96 locations

View Trial Details

Completed

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

NCT02054052

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: The First Affliliated Hospital of Guangzhou MC Guangzhou, Guangdong, China

View Trial Details

Completed

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

NCT03394105

Conditions: Neoplasms, Neoplasms by Site, Non-small Cell Carcinoma, +7 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Prognostic Factors on Malignant Pleural Effusion

NCT03276715

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +9 more
Locations: Queen Mary Hospital Hong Kong

View Trial Details